BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Zogenix Provides Corporate Update and Reports Second Quarter 2021 Financial Results

  Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced financial results for the three and six months ended June 30, 2021, and provided a corporate update.

  August 5, 2021

   · 

  12 min read
• Business

  Treace Medical Concepts Reports Second Quarter 2021 Financial Results

  Treace Medical Concepts, Inc., a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus, reported financial results for the second quarter ended June 30, 2021.

  August 5, 2021

   · 

  12 min read
• Business

  Codexis Reports Second Quarter 2021 Financial Results

  Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced financial results for the second quarter ended June 30, 2021 and provided a business update.

  August 5, 2021

   · 

  13 min read
• Business

  Gritstone Reports Second Quarter 2021 Financial Results and Business Update

  Gritstone bio, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, reported financial results for the second quarter ended June 30, 2021 and reviewed business highlights.

  August 5, 2021

   · 

  9 min read
• Business

  Opiant Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

  Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the three and six months ended June 30, 2021, and provided a corporate update.

  August 5, 2021

   · 

  12 min read
• Business

  T2 Biosystems Announces Second Quarter 2021 Financial Results

  T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the three months ended June 30, 2021.

  August 5, 2021

   · 

  9 min read
• Business

  Fluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 Million

  Fluidigm Corporation, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced financial results for the second quarter ended June 30, 2021.

  August 5, 2021

   · 

  19 min read
• Business

  Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update

  Progenity, Inc., an innovative biotechnology company, announced that it will report second quarter 2021 financial results on Thursday, August 12, 2021 after the close of financial markets.

  August 5, 2021

   · 

  1 min read
• Business

  Coherus BioSciences Reports Second Quarter 2021 Financial Results and Immuno-oncology and Biosimilar Pipeline Progress

  Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today reported financial results for the quarter ended June 30, 2021.

  August 5, 2021

   · 

  17 min read
• Business

  NextCure Reports Second Quarter 2021 Financial Results

  NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, reported second quarter 2021 financial results and provided a business update.

  August 5, 2021

   · 

  9 min read